Synthesis and Characterization of Binding of 5‐[76Br] Bromo‐3‐[[2(S)‐Azetidinyl]methoxy]pyridine, a Novel Nicotinic Acetylcholine Receptor Ligand, in Rat Brain
Open Access
- 1 September 1999
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 73 (3) , 1264-1272
- https://doi.org/10.1046/j.1471-4159.1999.0731264.x
Abstract
: 5‐[76Br]Bromo‐3‐[[2(S)‐azetidinyl]methoxy]‐pyridine ([76Br]BAP), a novel nicotinic acetylcholine receptor ligand, was synthesized using [76Br]bromide in an oxidative bromodestannylation of the corresponding trimethylstannyl compound. The radiochemical yield was 25%, and the specific radioactivity was on the order of 1 Ci/μmol. The binding properties of [76Br]BAP were characterized in vitro and in vivo in rat brain, and positron emission tomography (PET) experiments were performed in two rhesus monkeys. In association experiments on membranes of the cortex and thalamus, >90% of maximal specific [76Br]BAP binding was obtained after 60 min. The dissociation half‐life of [76Br]BAP was 51 ± 6 min in cortical membranes and 56 ± 3 min in thalamic membranes. Saturation experiments with [76Br]BAP revealed one population of binding sites with dissociation constant (KD) values of 36 ± 9 and 30 ± 9 pM in membranes of cortex and thalamus, respectively. The maximal binding site density (Bmax) values were 90 ± 17 and 207 ± 33 fmol/mg in membranes of cortex and thalamus, respectively. Scatchard plots were nonlinear, and the Hill coefficients were 76Br]BAP was high in the thalamus and presubiculum, moderate in the cortex and striatum, and low in the cerebellum and hippocampus. A similar pattern of [76Br]BAP accumulation was observed by ex vivo autoradiography. In vivo, binding of [76Br]BAP in whole rat brain was blocked by preinjection of (S)(‐)‐nicotine (0.3 mg/kg) by 27, 52, 68, and 91% at survival times of 10, 25, 40, 120, and 300 min, respectively. In a preliminary PET study in rhesus monkeys, the highest [76Br]BAP uptake was found in the thalamus, and radioactivity was displaceable by ~60% with cytisine and by 50% with (S)(‐)‐nicotine. The data of this study indicate that [76Br]BAP is a promising radioligand for the characterization of nicotinic acetylcholine receptors in vivo.Keywords
This publication has 35 references indexed in Scilit:
- In Vitro Evaluation of 11C‐Labeled (S)‐Nicotine, (S)‐3‐Methyl‐5‐(1‐Methyl‐2‐Pyrrolidinyl)isoxazole, and (R,S)‐1‐Methyl‐2‐(3‐Pyridyl)azetidine as Nicotinic Receptor Ligands for Positron Emission Tomography StudiesJournal of Neurochemistry, 1998
- (S)-(-)-[11C]Nicotine Binding Assessed by PETAlzheimer Disease & Associated Disorders, 1998
- 5-[I- ]Iodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptorsLife Sciences, 1998
- A-85380 [3-(2(S)-Azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligandNeuropharmacology, 1996
- Radioiodination of nicotine with specific activity high enough for mapping nicotinic acetylcholine receptorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Kinetic Analysis of Regional (S)(-)11C-Nicotine Binding in Normal and Alzheimer Brains In Vivo Assessment Using Positron Emission TomographyAlzheimer Disease & Associated Disorders, 1995
- Human nicotinic receptors—Their role in aging and dementiaNeurochemistry International, 1994
- In vivo labeling of nicotinic cholinergic receptors in brain with [3H]cytisineLife Sciences, 1994
- In vivo specific binding of [3H]-1-nicotine in the mouse brainLife Sciences, 1989
- Autoradiographic localization of [3H]nicotine binding sites in the rat brainNeuroscience Letters, 1985